Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Life Sci ; 340: 122424, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38242497

ABSTRACT

Inflammatory Bowel Disease (IBD) is a chronic and relapsing inflammatory condition characterized by severe symptoms such as diarrhea, fatigue, and weight loss. Growing evidence underscores the direct involvement of the nuclear factor-erythroid 2-related factor 2 (NRF2) in the development and progression of IBD, along with its associated complications, including colorectal cancer. The NRF2 pathway plays a crucial role in cellular responses to oxidative stress, and dysregulation of this pathway has been implicated in IBD. Flavones, a significant subclass of flavonoids, have shown pharmacological impacts in various diseases including IBD, through the NRF2 signaling pathway. In this study, we conducted a screening of compounds with a flavone structure and identified NJK15003 as a promising NRF2 activator. NJK15003 demonstrated potent NRF2 activation, as evidenced by the upregulation of downstream proteins, promoter activation, and NRF2 nuclear translocation in IBD cellular models. Treatment with NJK15003 effectively restored the protein levels of tight junctions in cells treated with dextran sodium sulfate (DSS) and in DSS-treated mice, suggesting its potential to protect cells from barrier integrity disruption in IBD. In DSS-treated mice, the administration of NJK15003 resulted in the prevention of body weight loss, a reduction in colon length shortening, and a decrease in the disease activity index. Furthermore, NJK15003 treatment substantially alleviated inflammatory responses and apoptotic cell death in the colon of DSS-treated mice. Taken together, this study proposes the potential utility of NRF2-activating flavone compounds, exemplified by NJK15003, for the treatment of IBD.


Subject(s)
Colitis , Flavones , Inflammatory Bowel Diseases , Sulfates , Mice , Animals , NF-E2-Related Factor 2/metabolism , Dextrans/metabolism , Colitis/chemically induced , Colitis/drug therapy , Colitis/metabolism , Flavones/pharmacology , Flavones/therapeutic use , Inflammatory Bowel Diseases/chemically induced , Inflammatory Bowel Diseases/drug therapy , Inflammatory Bowel Diseases/metabolism , Dextran Sulfate/toxicity , Mice, Inbred C57BL , Disease Models, Animal , Colon/metabolism
2.
J Neuroinflammation ; 20(1): 282, 2023 Nov 27.
Article in English | MEDLINE | ID: mdl-38012646

ABSTRACT

BACKGROUND: The gut microbiota has recently attracted attention as a pathogenic factor in Alzheimer's disease (AD). Microfold (M) cells, which play a crucial role in the gut immune response against external antigens, are also exploited for the entry of pathogenic bacteria and proteins into the body. However, whether changes in M cells can affect the gut environments and consequently change brain pathologies in AD remains unknown. METHODS: Five familial AD (5xFAD) and 5xFAD-derived fecal microbiota transplanted (5xFAD-FMT) naïve mice were used to investigate the changes of M cells in the AD environment. Next, to establish the effect of M cell depletion on AD environments, 5xFAD mice and Spib knockout mice were bred, and behavioral and histological analyses were performed when M cell-depleted 5xFAD mice were six or nine months of age. RESULTS: In this study, we found that M cell numbers were increased in the colons of 5xFAD and 5xFAD-FMT mice compared to those of wild-type (WT) and WT-FMT mice. Moreover, the level of total bacteria infiltrating the colons increased in the AD-mimicked mice. The levels of M cell-related genes and that of infiltrating bacteria showed a significant correlation. The genetic inhibition of M cells (Spib knockout) in 5xFAD mice changed the composition of the gut microbiota, along with decreasing proinflammatory cytokine levels in the colons. M cell depletion ameliorated AD symptoms including amyloid-ß accumulation, microglial dysfunction, neuroinflammation, and memory impairment. Similarly, 5xFAD-FMT did not induce AD-like pathologies, such as memory impairment and excessive neuroinflammation in Spib-/- mice. CONCLUSION: Therefore, our findings provide evidence that the inhibiting M cells can prevent AD progression, with therapeutic implications.


Subject(s)
Alzheimer Disease , Mice , Animals , Alzheimer Disease/pathology , Microglia/metabolism , M Cells , Neuroinflammatory Diseases , Amyloid beta-Peptides/metabolism , Memory Disorders , Mice, Knockout , Phenotype , Disease Models, Animal , Mice, Transgenic
3.
Phytomedicine ; 118: 154930, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37348246

ABSTRACT

BACKGROUND: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid-ß (Aß) and excessive neuroinflammation, resulting in neuronal cell death and cognitive impairments. Eugenol, a phenylpropene, is the main component of Syzygium aromaticum L. (Myrtaceae) and has multiple therapeutic effects, including neuroprotective and anti-inflammatory effects, through multimodal mechanisms. PURPOSE: We aimed to investigate the effect of eugenol on AD pathologies using a 5× familiar AD (5×FAD) mouse model. METHODS: Eight-month-old 5×FAD and wild-type mice were administered with eugenol (10 or 30 mg/kg/day, p.o) for 2 months. Y-maze and Morris water maze tests were performed to assess the cognitive function of mice. After the behavioral test, molecular analysis was conducted to investigate the therapeutic mechanism of eugenol. RESULTS: Our findings indicate that eugenol treatment effectively mitigated cognitive impairments in 5×FAD mice. This beneficial effect was associated with a decrease in AD pathologies, including neuronal cell loss and Aß deposition. Specifically, eugenol inhibited necroptosis activation and increased microglial phagocytosis, which were the underlying mechanisms for the observed reductions in neuronal cell loss and Aß deposition, respectively. CONCLUSION: Overall, our data suggest that eugenol would be a potential therapeutic candidate for AD.


Subject(s)
Alzheimer Disease , Neurodegenerative Diseases , Mice , Animals , Alzheimer Disease/metabolism , Eugenol/pharmacology , Eugenol/therapeutic use , Mice, Transgenic , Amyloid beta-Peptides/metabolism , Disease Models, Animal
4.
Nutrients ; 14(15)2022 Jul 29.
Article in English | MEDLINE | ID: mdl-35956303

ABSTRACT

Alzheimer's disease (AD) is an irreversible neurodegenerative disease characterized by memory and cognitive impairments. Neurogenesis, which is related to memory and cognitive function, is reduced in the brains of patients with AD. Therefore, enhancing neurogenesis is a potential therapeutic strategy for neurodegenerative diseases, including AD. Hesperidin (HSP), a bioflavonoid found primarily in citrus plants, has anti-inflammatory, antioxidant, and neuroprotective effects. The objective of this study was to determine the effects of HSP on neurogenesis in neural stem cells (NSCs) isolated from the brain of mouse embryos and five familial AD (5xFAD) mice. In NSCs, HSP significantly increased the proliferation of NSCs by activating adenosine monophosphate (AMP)-activated protein kinase (AMPK)/cAMP-response element-binding protein (CREB) signaling, but did not affect NSC differentiation into neurons and astrocytes. HSP administration restored neurogenesis in the hippocampus of 5xFAD mice via AMPK/brain-derived neurotrophic factor/tropomyosin receptor kinase B/CREB signaling, thereby decreasing amyloid-beta accumulation and ameliorating memory dysfunction. Collectively, these preclinical findings suggest that HSP is a promising candidate for the prevention and treatment of AD.


Subject(s)
Alzheimer Disease , Hesperidin , Neurodegenerative Diseases , AMP-Activated Protein Kinases/metabolism , Alzheimer Disease/metabolism , Animals , Disease Models, Animal , Hesperidin/metabolism , Hesperidin/pharmacology , Hesperidin/therapeutic use , Hippocampus/metabolism , Mice , Mice, Transgenic , Neurodegenerative Diseases/metabolism , Neurogenesis
5.
Environ Pollut ; 308: 119590, 2022 Sep 01.
Article in English | MEDLINE | ID: mdl-35752395

ABSTRACT

Bisphenol A (BPA) is pervasive in the environment, and exposure to BPA may increase the incidence of noncommunicable diseases like autoimmune diseases and cancer. Although BPA causes immunological problems at the cellular level, no system-level research has been conducted on this. Hence, in this study, we aimed to gain a better understanding of the biological response to BPA exposure and its association with immunological disorders. For that, we explored the transcriptome and the proteomic modifications at the systems and cellular levels following BPA exposure. Our integrated multi-omics data showed the alteration of the T cell receptor (TCR) signaling pathway at both levels. The proportion of enlarged T cells increased with upregulation of CD69, a surface marker of early T cell activation, even though the number of T cells reduced after BPA exposure. Additionally, on BPA exposure, the levels of pLCK and pSRC increased in T cells, while that of pLAT decreased. Following BPA exposure, we investigated cytokine profiles and discovered that chitinase 3 Like 1 and matrix metalloproteinase 9 were enriched in T cells. These results indicated that T cells were hyperactivated by CD69 stimulation, and phosphorylation of SRC accelerated on BPA exposure. Hence, alteration in the TCR signaling pathway during development and differentiation due to BPA exposure could lead to insufficient and hasty activation of TCR signaling in T cells, which could modify cytokine profiles, leading to increased environmental susceptibility to chronic inflammation or diseases, increasing the chance of autoimmune diseases and cancer. This study enhances our understanding of the effects of environmental perturbations on immunosuppression at molecular, cellular, and systematic levels following pubertal BPA exposure, and may help develop better predictive, preventative, and therapeutic techniques.


Subject(s)
Autoimmune Diseases , Proteomics , Benzhydryl Compounds/toxicity , Cytokines , Humans , Immune System , Phenols , Receptors, Antigen, T-Cell , Signal Transduction
6.
Rapid Commun Mass Spectrom ; 35(9): e9072, 2021 May 15.
Article in English | MEDLINE | ID: mdl-33617108

ABSTRACT

RATIONALE: This study aimed to develop methods to determine the identity and trace the origin of propellants used in shotshells. Specifically, the use of organic component and stable isotope analysis techniques, such as bulk stable isotope analysis (BSIA) and compound-specific isotope analysis (CSIA) techniques, for the study of shotshell propellants was investigated. METHODS: Nine samples of shotshell propellants from different manufacturing countries and brands were analyzed for explosive and additive components by gas chromatography/mass spectrometry and thin-layer chromatography. BSIA of the propellants was achieved using elemental analysis/isotope ratio mass spectrometry without a pretreatment process. For the CSIA of nitroglycerin, double-base powder propellants were extracted with ether, and the isotope ratios of carbon and nitrogen were measured by gas chromatography/isotope ratio mass spectrometry. RESULTS: Nine samples drawn from seven brands in four countries were classified into five groups by organic component analysis, while eight classification groups were identified by BSIA. Thus, two samples could not be distinguished from each other by either BSIA or organic component analysis. Subsequently, with the use of results obtained with CSIA for nitroglycerin, all the samples could be classified into different groups. These findings suggest that the nine propellant samples were all composed of different ingredients or raw materials from different sources. CONCLUSIONS: Stable isotope ratio analyses were performed for propellant discrimination. The combined BSIA, CSIA and organic component analysis techniques were able to successfully distinguish the nine shotshell propellants from seven brands sourced from four different countries, and the results suggested that the samples contained different ingredients or raw materials from different sources. We therefore can conclude that reliable results can be obtained using combined isotope analysis methods such as CSIA and BSIA for origin tracing and identity determination.

7.
Ann Rehabil Med ; 43(4): 483-489, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31499602

ABSTRACT

OBJECTIVE: To evaluate correlations between values of articulation tests and language tests for children with articulation disorder in Korea. METHODS: Data of outpatients with chief complaint of an articulation problem were retrospectively collected. Patients who underwent Urimal Test of Articulation and Phonation (U-TAP) with Assessment of Phonology and Articulation for Children (APAC), Preschool Receptive-Expressive Language Scale (PRES), or Receptive and Expressive Vocabulary Test (REVT) simultaneously were identified. Patients whose word-level percentages of correct consonants in U-TAP (UTAP_wC) were more than 2 standard deviations below the mean as diagnostic criteria for articulation disorder were selected. Those whose receptive language age (P_RLA), expressive language age (P_ELA), or combined language age (P_CLA) in PRES was delayed more than 24 months compared to their chronological age in months as diagnostic criteria for language disorder were excluded. RESULTS: Thirty-three children aged 3-6 years were enrolled retrospectively. PRES and U-TAP showed significant correlations for most of value relationships. PRES and APAC showed significant correlations for all value relationships except for receptive language age. All values of REVT were significantly correlated with all values from U-TAP, but not with any value from APAC. Articulation tests U-TAP and APAC showed significant correlations between percentages of correct consonants. Language tests PRES and REVT showed significant correlations for all value relationships. CONCLUSION: This study suggests that articulation abilities and language abilities might be correlated in children with articulation disorder.

8.
Am J Nephrol ; 24(2): 178-87, 2004.
Article in English | MEDLINE | ID: mdl-14764974

ABSTRACT

BACKGROUND: The familial clustering of vesicoureteral reflux (VUR) has suggested a genetic basis. This study was designed to investigate the genetic polymorphism of the renin-angiotensin system (RAS) in Korean children. METHODS: Genetic polymorphism of angiotensin-converting enzyme (ACE) and angiotensin II receptor genes was evaluated in 67 primary VUR patients and compared to 58 controls with no urological abnormalities. To detect the relation of the risk factors of primary VUR with the genetic polymorphism, the distribution of ACE, AT1 and AT2 genotypes after stratification by risk factors was also studied in the primary VUR patients. RESULTS: The incidence of AT2 A-1332G transition was significantly lower in primary VUR patients (p = 0.047). Furthermore, in the case of combination of ACE and AT2 gene, a significantly lower incidence of primary VUR was seen with II genotype of ACE and A-1332G transition in the AT2 receptor gene (p = 0.003). Concerning the risk factors of primary VUR, there were no biologically significant results. CONCLUSIONS: These findings indicate that a lower incidence of AT2 A-1332G transition is seen in primary VUR patients, at least in the Korean population. Also, in the case of combination of ACE and AT2 gene, the combination of ACE II genotype and AT2 A-1332G transition occurs infrequently in primary VUR.


Subject(s)
Polymorphism, Genetic , Renin-Angiotensin System/genetics , Vesico-Ureteral Reflux/genetics , Female , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...